ZYMTRONIX CATALYTIC SYSTEMS, INC.
Ithaca, NY · Biotech · Private
Chemoenzymatic flow reactors with co-immobilized enzymes for continuous synthesis of complex glycans, specifically human milk oligosaccharides (HMOs).
zymtronix.com →- Grants
- $7.9M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 31
- 2 granted · 29 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Enzyme-based Magnetic Catalysts for Active Pharmaceutical Intermediates (APIs) Manufacturing | $1,087,654 | |
| Federal grant | Department of Agriculture · A Seed-coating Mixed Enzyme Formula For The Control Of Fungal And Bacterial Pathogens | $86,196 | |
| Federal grant | Department of Health and Human Services · Phase I · A high-throughput cell-free profiling platform integrating high metabolic diversity for chemical safety assessment | $224,930 | |
| Federal grant | Department of Health and Human Services · Phase I · Flow processes for the chemoenzymatic synthesis of fucosylated and sialylated glycans | $224,987 | |
| Federal grant | Department of Health and Human Services · Phase II · Multi-gram enzymatic production of complex glycans by flow processes | $354,457 | |
| Federal grant | Department of Health and Human Services · Phase II · Multi-gram enzymatic production of complex glycans by flow processes | $2,527,145 | |
| Federal grant | Department of Health and Human Services · Phase II · Multi-gram enzymatic production of complex glycans by flow processes | $1,137,877 | |
| Federal grant | Department of Health and Human Services · Phase II · Scaling-up flow processes for the chemoenzymatic synthesis of a sialylated glycan | $1,144,101 | |
| Federal grant | Department of Health and Human Services · Phase II · Scaling-up flow processes for the chemoenzymatic synthesis of a sialylated glycan | $1,114,537 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2623 | SNC THERAPEUTICS, INC. | — | $250K |
| 2624 | Dome Therapeutics, LLC | — | $250K |
| 2625 | X1 Biotech Inc. | — | $235K |
| 2626 | ZYMTRONIX CATALYTIC SYSTEMS, INC. | — | — |
| 2627 | HUNTERIAN MEDICINE LLC | — | $230K |
| 2628 | Daya CNS, LLC | — | $228K |
| 2629 | Zepteon, Inc | — | $210K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Enzymatically Produced Biopesticidesapplication
- Biocatalytic Manufacture Of Sugar Nucleotidesapplication
- Magnetic Macroporous Polymeric Hybrid Scaffolds For Immobilizing Bionanocatalystsapplication
- Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicalsapplication
- Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicalsgranted
- Modular Glycan Production With Immobilized Bionanocatalystsapplication
- Biomanufacturing Of Oligosaccharides And Derivatives From Simple Sugarsapplication
- Immobilized Enzymes And Microsomes On Magnetic Scaffoldsapplication
- Printable Magnetic Powders And 3D Printed Objects For Bionanocatalyst Immobilizationapplication
- Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicalsgranted
- Magnetic Macroporous Polymeric Hybrid Scaffolds For Immobilizing Bionanocatalystsapplication
- Magnetically Immobilized Metabolic Enzymes And Cofactor Systemsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.